Cervical Cancer Incidence Pre- vs. Post-HPV Vaccination Eras
This blog entry provides a quick synopsis of a new study looking at state-level variance in declines in cervical cancer compared to HPV vaccination rates.
This blog entry provides a quick synopsis of a new study looking at state-level variance in declines in cervical cancer compared to HPV vaccination rates.
This blog entry discusses the recommended HPV dose schedule for children and adolescents.
This blog entry includes a summary of a recent poll from Kaiser Family Foundation (KFF) on recent changes to the childhood vaccine schedule.
AIM invites interested parties to participate in its Immunization Program and Birthing Institution Community of Practice to Optimize Infant Protection Against RSV.
This blog entry includes a summary of the talking points from “Navigating Conflicting Vaccination Recommendations: Guidance for Clinicians,” published in JAMA.
This handout outlines how birthing institution participation in VFC can ensure equitable access to vaccines, save money, and protect newborns from RSV and hepatitis B.
Likely you’ve heard some back-and-forth recently about the use of aluminum as an adjuvant in vaccines. Here’s what you need to know from both sides of the argument.
On July 9, 2025, the FDA released its decision to approve the supplemental Biologics License Application (BLA) for SPIKEVAX, but only for certain ages at high risk.
Here’s what you need to know about the study, Effectiveness of the Influenza Vaccine During the 2024-2025 Respiratory Viral Season.
The American Academy of Pediatrics (AAP) is updating the roster of Chapter Immunization Representatives (CIRs) and is seeking to maintain an updated listing.